Dr. Rami Raouf Eltaraboulsi, MD

  • Rockville, MD
  • Rheumatologist
NPI1427477363PAC ID8729334750
Medicare services, 2024
64,532
Medicare patients, 2024
892
Part D claims, 2024
1,292
Publications
2
MIPS score, 2024
86
Practice address
14995 Shady Grove Rd Suite 500, Rockville, MD 20850
Practice phone
Call (301) 942-3126
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Arthritis and Rheumatism Associates - Rockville 5

Clinical Lab - Full Service · Rockville, Maryland

See all 4 affiliations

Find Dr. Eltaraboulsi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Rami Raouf Eltaraboulsi is a rheumatologist in Rockville, Maryland

Dr. Eltaraboulsi practices at Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland.

Dr. Eltaraboulsi's NPI, 1427477363, was assigned on April 8, 2014. Dr. Eltaraboulsi graduated from University of North Carolina at Chapel Hill School of Medicine in 2020. Dr. Eltaraboulsi holds Maryland license D0089215.

NPI and contact details
Medicare PAC ID
8729334750
NPI enumeration date
April 8, 2014
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(301) 942-3126
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
32
Medical school graduation
2020

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Rami Raouf Eltaraboulsi practices at Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland

Dr. Eltaraboulsi's primary practice is Arthritis and Rheumatism Associates - Rockville 5, at 14995 Shady Grove Rd Suite 500, Rockville, MD 20850. The practice phone is (301) 942-3126.

  • Arthritis and Rheumatism Associates - Rockville 5
    14995 Shady Grove Rd Suite 500, Rockville, MD 20850Phone(301) 942-3126

Source: Dmand AI Affiliation Data

Dr. Rami Raouf Eltaraboulsi is affiliated with 2 sites of care and 2 medical groups

Dr. Eltaraboulsi's primary practice is Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland. The medical group on file is Amber Hill Therapy Centers. Dmand AI also links Dr. Eltaraboulsi to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Eltaraboulsi's employer is on file too: a clinical lab.

See all 4 affiliations for Dr. Eltaraboulsi

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Rami Raouf Eltaraboulsi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eltaraboulsi practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Arthritis and Rheumatism Associates - Rockville 5Available with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Eltaraboulsi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Rami Raouf Eltaraboulsi is one of 177 rheumatologists in Maryland

Rheumatology is Dr. Eltaraboulsi's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Eltaraboulsi's licenses on file in 2 states: Maryland and Virginia.

Specialties and state licenses

  • Rheumatology, MarylandPrimaryLicense D0089215 · taxonomy 207RR0500X
  • Internal medicine, VirginiaLicense 0101260455 · taxonomy 207R00000X

Rheumatologists near Dr. Eltaraboulsi

Counts of rheumatologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Rami Raouf Eltaraboulsi billed Medicare for 64,532 services in 2024

CMS data shows 64,532 Medicare services from Dr. Eltaraboulsi across 56 procedure codes in 2024, for 892 Medicare patients. Medicare paid $960,259 for them. Every service was in an office.

Medicare services, 202464,532
Medicare patients892
Paid by Medicare$960,259
Procedure codes56

Dr. Eltaraboulsi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 71,9062024: 55,96722%
Other services
2023: 1,9402024: 2,85347%
Lab and pathology
2023: 2,8512024: 2,49712%
Office and hospital visits
2023: 1,1392024: 1,25410%
Tests and treatments
2023: 1,0202024: 87414%
Surgery
2023: 6342024: 57310%
Imaging
2023: 6732024: 51424%

Dr. Eltaraboulsi compared with the Maryland median for rheumatologists, 2024

  • Dr. Eltaraboulsi
  • Maryland median
Medicare services
64,532vs 3,91516.5 times
Medicare patients
892vs 3003.0 times
Part D claims
1,186vs 78252% above

Medians across 168 rheumatologists in Maryland with Dmand AI profiles that report each measure.

Dr. Eltaraboulsi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Eltaraboulsi

Need commercial claims for Dr. Eltaraboulsi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Eltaraboulsi and other rheumatologists in Maryland.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Rami Raouf Eltaraboulsi treated 892 Medicare patients in 2024, average age 76

CMS counts 892 Medicare patients who saw Dr. Eltaraboulsi in 2024. The largest group is 65 to 74, with 370 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eltaraboulsi's median patient age at 66, with 72% women.

Medicare patients, 2024892
Average age76
Average risk score1.11
Also on Medicaid10%

Dr. Eltaraboulsi's Medicare patients by age, 2024

Dr. Eltaraboulsi's Medicare patients by sex, 2024

  • Women69778%
  • Men19522%

Chronic conditions among Dr. Eltaraboulsi's Medicare patients, 2024

  1. Arthritis75%
  2. High cholesterol75%
  3. High blood pressure73%
  4. Osteoporosis62%
  5. Diabetes27%
  6. Ischemic heart disease24%
  7. Anxiety23%
  8. Mood disorders23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Eltaraboulsi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women72%
  • Men26%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Rami Raouf Eltaraboulsi wrote 1,292 Medicare Part D claims in 2024

In 2024, Dr. Eltaraboulsi wrote 1,292 Medicare Part D claims for 287 patients. 93% of them were for generic drugs. CMS names the drug for 1,186 of them, across 26 drugs with 11 or more claims each, at $558,819 in total drug cost. In 2023, CMS named 909 claims across 19 drugs.

Part D claims, 20241,292
Drugs named by CMS26
Total drug cost$558,819
Part D patients287

Dr. Eltaraboulsi's Part D claims by kind of drug, 2024

  • Generic1,197 claims93%
  • Brand-name and other95 claims7%

Dr. Eltaraboulsi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Eltaraboulsi's Part D claims, 2024

  • Opioids2%31 of 1,292 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9092024: 1,18630%

Drugs named by CMS: 26 in 2024, 19 in 2023.

See all prescribing by Dr. Eltaraboulsi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Rami Raouf Eltaraboulsi scored 86 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Eltaraboulsi for performance year 2024, reported as part of a group. Dr. Eltaraboulsi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eltaraboulsi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Eltaraboulsi's MIPS scores, performance year 2024

  • 86of 100Final score
  • 93.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 59of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find rheumatologists like Dr. Eltaraboulsi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Rami Raouf Eltaraboulsi has 2 publications on record

Dmand AI links 2 papers to Dr. Eltaraboulsi, published from 2019 to 2024. Dr. Eltaraboulsi's most frequent co-authors are Amanda E. Nelson, MD, Jordan B. Renner, MD and Virginia Steen.

Papers2
Years published2019 to 2024

Dr. Eltaraboulsi's most frequent co-authors

Recent publications by Dr. Eltaraboulsi

See all 2 publications and co-authors

See who Dr. Eltaraboulsi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Eltaraboulsi works with, so you can find a warm path to the right rheumatologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Rami Raouf Eltaraboulsi received $1,462 in industry payments from 2019 to 2025

CMS Open Payments shows 42 general payments to Dr. Eltaraboulsi from 10 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 88% of the total. Abbvie Inc. paid the most, $326.

General payments to Dr. Eltaraboulsi by program year, 2019 to 2025

General payments to Dr. Eltaraboulsi by kind, 2019 to 2025

$1.5Kin total
  • Food and beverage$1,27988%
  • Education$18312%

Companies that paid Dr. Eltaraboulsi the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Eltaraboulsi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Rami Raouf Eltaraboulsi graduated from University of North Carolina at Chapel Hill School of Medicine

Dr. Eltaraboulsi graduated from University of North Carolina at Chapel Hill School of Medicine in 2020.

  1. Medical schoolUniversity of North Carolina at Chapel Hill School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Rami Raouf Eltaraboulsi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Rami Raouf Eltaraboulsi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Rami Raouf Eltaraboulsi's NPI number?

Dr. Rami Raouf Eltaraboulsi's NPI number is 1427477363. It was assigned on April 8, 2014, and it is active in the NPI Registry.

What kind of doctor is Dr. Rami Raouf Eltaraboulsi?

Dr. Rami Raouf Eltaraboulsi is a rheumatologist in Rockville, Maryland. The primary specialty in the NPI Registry is Rheumatology Physician (taxonomy code 207RR0500X).

Where does Dr. Rami Raouf Eltaraboulsi practice?

Dr. Eltaraboulsi practices at 14995 Shady Grove Rd Suite 500, Rockville, MD 20850. Dr. Eltaraboulsi's primary practice is Arthritis and Rheumatism Associates - Rockville 5 in Rockville, Maryland. Dmand AI also links Dr. Eltaraboulsi to 1 group practice or clinic and 1 medical group.

What is Dr. Rami Raouf Eltaraboulsi's office phone number?

The practice phone on file for Dr. Eltaraboulsi is (301) 942-3126.

What is Dr. Rami Raouf Eltaraboulsi's medical license number?

Dr. Eltaraboulsi holds Maryland license D0089215, one of the licenses on file in 2 states.

Which states has Dr. Rami Raouf Eltaraboulsi been licensed in?

Dmand AI has state licenses on file for Dr. Eltaraboulsi in Maryland and Virginia.

What medical group is Dr. Rami Raouf Eltaraboulsi part of?

Dr. Eltaraboulsi is linked to Amber Hill Therapy Centers. Dmand AI links Dr. Eltaraboulsi to 1 more medical group.

Does Dr. Rami Raouf Eltaraboulsi accept Medicare?

Yes. CMS data shows Dr. Eltaraboulsi billed Medicare for 64,532 services in 2024, and Dr. Eltaraboulsi accepts Medicare assignment.

Does Dr. Rami Raouf Eltaraboulsi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Eltaraboulsi as offering telehealth services.

What is Dr. Rami Raouf Eltaraboulsi's MIPS score?

Dr. Eltaraboulsi's MIPS final score for performance year 2024 is 86 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Rami Raouf Eltaraboulsi see?

CMS counts 892 Medicare patients who saw Dr. Eltaraboulsi in 2024, with an average age of 76.

What services does Dr. Rami Raouf Eltaraboulsi bill to Medicare?

In 2024, Dr. Eltaraboulsi's most billed Medicare services were injected or infused drug (J3262), injected or infused drug (J3111) and injected or infused drug (J0897).

Where did Dr. Rami Raouf Eltaraboulsi go to medical school?

Dr. Eltaraboulsi graduated from University of North Carolina at Chapel Hill School of Medicine in 2020.

What drugs does Dr. Rami Raouf Eltaraboulsi prescribe most?

In 2024 Medicare Part D data, Dr. Eltaraboulsi's most prescribed drugs by claims were Alendronate Sodium, Allopurinol and Meloxicam.

Has Dr. Rami Raouf Eltaraboulsi received payments from drug or device companies?

CMS Open Payments shows $1,462 in general payments to Dr. Eltaraboulsi from 10 companies from 2019 to 2025. The largest total came from Abbvie Inc.

How long has Dr. Rami Raouf Eltaraboulsi been practicing?

Dr. Eltaraboulsi graduated from medical school in 2020, 6 years ago.

Does Dr. Rami Raouf Eltaraboulsi do research?

Dmand AI links 2 publications to Dr. Eltaraboulsi, published from 2019 to 2024.

Who does Dr. Rami Raouf Eltaraboulsi publish with?

Dr. Eltaraboulsi's most frequent co-authors are Amanda E. Nelson, MD (1 shared paper), Jordan B. Renner, MD (1 shared paper) and Virginia Steen (1 shared paper).

Selling to rheumatology practices?

See rheumatologists in Maryland by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)